From skin patches to minimally invasive microneedle system and innovative skin insertion platforms, and from solid or liquid dosing, to existing or new drugs, we have a significant and robust pipeline of carefully selected drug candidates in various stages of clinical development.Our research is always underpinned by exceptional science and driven by our years’ of expertise in drug delivery and pharmaceutical product development.
Product Pipeline & Licensing Opportunities
Microneedle Patches for Ibuprofen and Diclofenac
Transdermal Patch dossiers available for filing:
Teriparatide Solid Dose SC Injection using the Micropatch platform
Over 20 Injectable drugs in development, of which over 10 are in clinical development.
For licensing and collaboration please contact Business Development: BD@nemaura.co.uk